Adverse events392

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 392

Type	Event	Organ system	Group	Affected	At risk	Events
other	Fatigue	General disorders	Suvorexant	34	521	40
other	Fatigue	General disorders	Placebo	5	258	5
other	Fatigue	General disorders	Suvorexant (DB Treatment)/Suvorexant (DB Discontinuation)	0	156	0
other	Fatigue	General disorders	Suvorexant (DB Treatment)/Placebo (DB Discontinuation)	0	166	0
other	Fatigue	General disorders	Placebo (DB Treatment)/Placebo (DB Discontinuation)	1	162	1
other	Fatigue	General disorders	Suvorexant (DB Treatment)/Suvorexant (DB Run-out)/Follow-up	0	260	0
other	Fatigue	General disorders	Suvorexant (DB Treatment)/Placebo (DB Run-out)/Follow-up	0	261	0
other	Fatigue	General disorders	Placebo (DB Treatment)/Placebo (DB Run-out)/Follow-up	0	258	0
other	Nasopharyngitis	Infections and infestations	Suvorexant	42	521	53
other	Nasopharyngitis	Infections and infestations	Placebo	20	258	25
other	Nasopharyngitis	Infections and infestations	Suvorexant (DB Treatment)/Suvorexant (DB Discontinuation)	5	156	5
other	Nasopharyngitis	Infections and infestations	Suvorexant (DB Treatment)/Placebo (DB Discontinuation)	2	166	2
other	Nasopharyngitis	Infections and infestations	Placebo (DB Treatment)/Placebo (DB Discontinuation)	4	162	4
other	Nasopharyngitis	Infections and infestations	Suvorexant (DB Treatment)/Suvorexant (DB Run-out)/Follow-up	2	260	2
other	Nasopharyngitis	Infections and infestations	Suvorexant (DB Treatment)/Placebo (DB Run-out)/Follow-up	0	261	0
other	Nasopharyngitis	Infections and infestations	Placebo (DB Treatment)/Placebo (DB Run-out)/Follow-up	1	258	1
other	Upper respiratory tract infection	Infections and infestations	Suvorexant	28	521	32
other	Upper respiratory tract infection	Infections and infestations	Placebo	11	258	13
other	Upper respiratory tract infection	Infections and infestations	Suvorexant (DB Treatment)/Suvorexant (DB Discontinuation)	1	156	1
other	Upper respiratory tract infection	Infections and infestations	Suvorexant (DB Treatment)/Placebo (DB Discontinuation)	2	166	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01021813/events

API reference For AI assistants

Adverse events392

Sources 3

Read this list from software.